Publikationen

Afzali AM, Ruck T, Herrmann AM, Iking J, Sommer C, Kleinschnitz C, Preu?e C, Stenzel W, Budde T, Wiendl H, Bittner S, Meuth SG (2016)
The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells.
Am J Physiol Cell Physiol 311(4):C583-C595.

Attal N, de Andrade DC, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, Raicher I, Üçeyler N, Sommer C, Bouhassira D (2016)
Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Lancet Neurol 15(6):555-65.

Auer-Grumbach M, Toegel S, Schabhüttl M, Weinmann D, Chiari C, Bennett DLH, Beetz C, Klein D, Andersen PM, Böhme I, Fink-Puches R, Gonzalez M, Harms MB, Motley W, Reilly MM, Renner W, Rudnik-Schöneborn S, Schlotter-Weigel B, Themistocleous AC, Weishaupt JH, Ludolph AC, Wieland T, Tao F, Abreu L, Windhager R, Zitzelsberger M, Strom TM, Walther T, Scherer SS, Züchner S, Martini R, Senderek J (2016)
Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies.
Am J Hum Genet 99(3):607-623.

Baig AA, Haining EJ, Geuss E, Beck S, Swieringa F, Wanitchakool P, Schuhmann MK, Stegner D, Kunzelmann K, Kleinschnitz C, Heemskerk JW, Braun A, Nieswandt B (2016)
TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice-Brief Report.
Arterioscler Thromb Vasc Biol 36(11):2152-2157.

Baum P, Kosacka J, Estrela-Lopis I, Woidt K, Serke H, Paeschke S, Stockinger M, Klöting N, Blüher M, Dorn M, Classen J, Thiery J, Bechmann I, Toyka KV, Nowicki M (2016)
The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN).
Metabolism 65(4):391-405.

Buttmann M, Seuffert L, Mäder U, Toyka KV (2016)
Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study.
Neurology 86(23):2203-7.

Canesi M, Giordano R, Lazzari L, Isalberti M, Isaias IU, Benti R, Rampini P, Marotta G, Colombo A, Cereda E, Dipaola M, Montemurro T, Viganò M, Budelli S, Montelatici E, Lavazza C, Cortelezzi A, Pezzoli G (2016)
Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy. 
J Transl Med 14(1):127.

Canessa A, Pozzi NG, Arnulfo G, Brumberg J, Reich MM, Pezzoli G, Ghilardi MF, Matthies C, Steigerwald F, Volkmann J, Isaias IU (2016)
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.
Front Hum Neurosci 10:611.

Contarino MF, Smit M, van den Dool J, Volkmann J, Tijssen MA (2016)
Corrigendum: Unmet Needs in the Management of Cervical Dystonia.
Front Neurol 7:232.

Contarino MF, Smit M, van den Dool J, Volkmann J, Tijssen MA (2016)
Unmet Needs in the Management of Cervical Dystonia.
Front Neurol 7:165.

de Cuba CM, Albanese A, Antonini A, Cossu G, Deuschl G, Eleopra R, Galati A, Hoffmann CF, Knudsen K, Landi A, Lanotte MM, Marcante A, Mosch A, Pilleri M, Reich MM, Ricchi V, Rinaldo S, Romito LM, Saba FS, Sacristan HE, Schuurman PR, Trezza A, van den Munckhof P, Volkmann J, Zibetti M, Contarino MF (2016)
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review.
Parkinsonism Relat Disord 32:108-115.

De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C (2016)
Thromboinflammation in Stroke Brain Damage.
Stroke 47(4):1165-72.

Denorme F, Langhauser F, Desender L, Vandenbulcke A, Rottensteiner H, Plaimauer B, François O, Andersson T, Deckmyn H, Scheiflinger F, Kleinschnitz C, Vanhoorelbeke K, De Meyer SF (2016)
ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.
Blood 127(19):2337-45.

Dipaola M, Pavan EE, Cattaneo A, Frazzitta G, Pezzoli G, Cavallari P, Frigo CA, Isaias IU (2016)
Mechanical Energy Recovery during Walking in Patients with Parkinson Disease. PLoS ONE 11(6):e0156420.

Dittmeier M, Kraft P, Schuhmann MK, Fluri F, Kleinschnitz C. (2016) Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism.
Thromb Haemost 115(4):835-43.

Dittmeier M, Wassmuth K, Schuhmann MK, Kraft P, Kleinschnitz C, Fluri F (2016)
Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke.
Curr eurovasc Res 13(3):199-206.

Doppler K, Appeltshauser L, Villmann C, Martin C, Peles E, Krämer HH, Haarmann A, Buttmann M, Sommer C (2016)
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
Brain 139(Pt 10):2617-2630.

Doppler K, Schütt M, Sommer C (2016)
Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.
Cephalalgia 36(14):1379-1384.

Fasano A, Schlenstedt C, Herzog J, Plotnik M, Rose FEM, Volkmann J, Deuschl G (2016)
Split-belt locomotion in Parkinson's disease links asymmetry, dyscoordination and sequence effect. 
Gait Posture 48:6-12.

Fischer HJ, van den Brandt J, Lingner T, Odoardi F, Flügel A, Weishaupt A, Reichardt HM (2016) 
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
J Neuroimmunol 290:26-32.

Göbel K, Kraft P, Pankratz S, Gross CC, Korsukewitz C, Kwiecien R, Mesters R, Kehrel BE, Wiendl H, Kleinschnitz C, Meuth SG (2016)
Prothrombin and factor X are elevated in multiple sclerosis patients. 
Ann Neurol 80(6):946-951.

Göbel K, Pankratz S, Asaridou CM, Herrmann AM, Bittner S, Merker M, Ruck T, Glumm S, Langhauser F, Kraft P, Krug TF, Breuer J, Herold M, Gross CC, Beckmann D, Korb-Pap A, Schuhmann MK, Kuerten S, Mitroulis I, Ruppert C, Nolte MW, Panousis C, Klotz L, Kehrel B, Korn T, Langer HF, Pap T, Nieswandt B, Wiendl H, Chavakis T, Kleinschnitz C, Meuth SG (2016)
Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells.
Nat Commun 7:11626.

Groh J, Basu R, Stanley ER, Martini R (2016)
Cell-Surface and Secreted Isoforms of CSF-1 Exert Opposing Roles in Macrophage-Mediated Neural Damage in Cx32-Deficient Mice.
J Neurosci 36(6):1890-901.

Groh J, Friedman HC, Orel N, Ip CW, Fischer S, Spahn I, Schäffner E, Hörner M, Stadler D, Buttmann M, Varallyay C, Solymosi L, Sendtner M, Peterson AC, Martini R (2016)
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Hum Mol Genet 25(21):4686-4702.

Groh J, Ribechini E, Stadler D, Schilling T, Lutz MB, Martini R (2016)
Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease.
Glia 64(5):792-809.

Grünewald B, Bennett JL, Toyka KV, Sommer C, Geis C (2016)
Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.
Int J Mol Sci 17:9.

Halbgebauer S, Huss A, Buttmann M, Steinacker P, Oeckl P, Brecht I, Weishaupt A, Tumani H, Otto M (2016)
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
J Neurol 263(5):954-960.

Havrdova T, Boucek P, Saudek F, Voska L, Lodererova A, Üçeyler N, Vondrova H, Skibova J, Lipar K, Sommer C (2016)
Severe Epidermal Nerve Fiber Loss in Diabetic Neuropathy Is Not Reversed by Long-Term Normoglycemia After Simultaneous Pancreas and Kidney Transplantation.
Am J Transplant 16(7):2196-201.

Hopp S, Albert-Weissenberger C, Mencl S, Bieber M, Schuhmann MK, Stetter C, Nieswandt B, Schmidt PM, Monoranu CM, Alafuzoff I, Marklund N, Nolte MW, Sirén AL, Kleinschnitz C (2016)
Targeting coagulation factor XII as a novel therapeutic option in brain trauma.
Ann Neurol 79(6):970-82.

Huss A, Buttmann M, Brecht I, Weishaupt A, Otto M, Tumani H (2016)
Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.
Expert Rev Mol Diagn 16(12):1353-1356.

Huss AM, Halbgebauer S, Öckl P, Trebst C, Spreer A, Borisow N, Harrer A, Brecht I, Balint B, Stich O, Schlegel S, Retzlaff N, Winkelmann A, Roesler R, Lauda F, Yildiz Ö, Voß E, Muche R, Rauer S, Bergh FT, Otto M, Paul F, Wildemann B, Kraus J, Ruprecht K, Stangel M, Buttmann M, Zettl UK, Tumani H (2016)
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
J Neurol 263(12):2499-2504.

Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A (2016)
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease.
Front Aging Neurosci 8:196.

Israel I, Ohsiek A, Al-Momani E, Albert-Weissenberger C, Stetter C, Mencl S, Buck AK, Kleinschnitz C, Samnick S, Sirén AL (2016)
Combined [(18)F]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice.
J Neuroinflammation 13(1):140.

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
J Neuroinflammation 13(1):281.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
J Neuroinflammation 13(1):280.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M, in cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. 
J Neuroinflammation 13(1):279.

Klein D, Martini R (2016)
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Brain Res 1641(Pt A):130-138.

Kleinschnitz C, Mencl S, Kleikers PW, Schuhmann MK, G López M, Casas AI, Sürün B, Reif A, Schmidt HH (2016)
NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage.
J Cereb Blood Flow Metab 36(9):1508-12.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Neuromyelitis Optica Study Group , Albrecht P, Ayzenberg I, Bischof F, Böttcher T, Brettschneider J, Buttmann M, Ettrich B, Gass A, Guthke K, Hoffmann F, Kaste M, Kermer P, Kern P, Köhler W, Kolesilova E, Langel S, Liebetrau M, Melms A, Metz I, Münch C, Niehaus S, Pellkofer H, Riedlinger A, Röpke L, Rommer P, Ruschil C, Schippling S, Stoppe M, Tünnerhoff J, Veauthier C, Walter A, Wandinger KP, Weber MS, Weissert R, Wilke C, Young K, Zentner C, Zettl U (2016)
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.
Ann Neurol 79(2):206-16.

Klotz L, Kuzmanov I, Hucke S, Gross CC, Posevitz V, Dreykluft A, Schulte-Mecklenbeck A, Janoschka C, Lindner M, Herold M, Schwab N, Ludwig-Portugall I, Kurts C, Meuth SG, Kuhlmann T, Wiendl H (2016)
B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity.
Proc Natl Acad Sci U S A 113(41):E6182-E6191.

Kraft P, Schleicher R, Olbrich M, Schuhmann MK, Blanz KD, Emschermann F, Ebenhoech S, Starz C, Hilgendorf I, Meuth SG, Edlich F, Kleinschnitz C, Langer HF (2016)
Platelet derived FasL contributes to apoptosis in stroke.
Thromb Haemost 116(5):998-1000.

Krupka J, May F, Weimer T, Pragst I, Kleinschnitz C, Stoll G, Panousis C, Dickneite G, Nolte MW (2016)
The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
PLoS ONE 11(1):e0146783.

Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'Hooghe M, Hutchinson M, De Keyser J, Kieseier BC, Kümpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L, European Long-term Follow-up Study Group in Interferon ?-1b in Secondary-progressive Multiple Sclerosis (2016)
A 10-year follow-up of the European multicenter trial of interferon ?-1b in secondary-progressive multiple sclerosis.
Mult Scler 22(4):533-43.

Leinders M, Doppler K, Klein T, Deckart M, Rittner H, Sommer C, Üçeyler N (2016)
Increased cutaneous miR-let-7d expression correlates with small nerve fiber pathology in patients with fibromyalgia syndrome.
Pain 157(11):2493-2503.

Leinders M, Üçeyler N, Pritchard RA, Sommer C, Sorkin LS (2016)
Increased miR-132-3p expression is associated with chronic neuropathic pain.
Exp Neurol 283(Pt A):276-86.

Lenders M, Canaan-Kühl S, Krämer J, Duning T, Reiermann S, Sommer C, Stypmann J, Blaschke D, Üçeyler N, Hense HW, Brand SM, Wanner C, Weidemann F, Brand E (2016)
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up. 
J Am Soc Nephrol 27(3):952-62.

Lenders M, Hennermann JB, Kurschat C, Rolfs A, Canaan-Kühl S, Sommer C, Üçeyler N, Kampmann C, Karabul N, Giese AK, Duning T, Stypmann J, Krämer J, Weidemann F, Brand SM, Wanner C, Brand E (2016)
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.
Orphanet J Rare Dis 11(1):88.

Martini R, Willison H (2016)
Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?
Glia 64(4):475-86.

May F, Krupka J, Fries M, Thielmann I, Pragst I, Weimer T, Panousis C, Nieswandt B, Stoll G, Dickneite G, Schulte S, Nolte MW (2016)
FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
Br J Haematol 173(5):769-78.

Moldovan M, Rosberg MR, Alvarez S, Klein D, Martini R, Krarup C (2016)
Aging-associated changes in motor axon voltage-gated Na(+) channel function in mice.
Neurobiol Aging 39:128-39.

Münzer P, Walker-Allgaier B, Geue S, Geuss E, Hron G, Rath D, Eißler D, Winter S, Schaeffeler E, Meinert M, Schaller M, Greinacher A, Schwab M, Geisler T, Kleinschnitz C, Lang F, Gawaz M, Borst O (2016)
PDK1 Determines Collagen-Dependent Platelet Ca2+ Signaling and Is Critical to Development of Ischemic Stroke In Vivo.
Arterioscler Thromb Vasc Biol 36(8):1507-16.

Oder D, Üçeyler N, Liu D, Hu K, Petritsch B, Sommer C, Ertl G, Wanner C, Nordbeck P (2016)
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y. 
BMJ Open 6(4):e010422.

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU, in cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. 
J Neuroinflammation 13(1):282.

Patzig J, Kusch K, Fledrich R, Eichel MA, Lüders KA, Möbius W, Sereda MW, Nave KA, Martini R, Werner HB (2016)
Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
Glia 64(1):155-74.

Pfeuffer S, Ruck T, Kleinschnitz C, Wiendl H, Meuth SG (2016)
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.
Expert Rev Neurother 16(6):689-700.

Politei JM, Bouhassira D, Germain DP, Goizet C, Guerrero-Sola A, Hilz MJ, Hutton EJ, Karaa A, Liguori R, Üçeyler N, Zeltzer LK, Burlina A (2016)
Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment.
CNS Neurosci Ther 22(7):568-76.

Pozzi NG, Arnulfo G, Canessa A, Steigerwald F, Nickl R, Homola GA, Fato MM, Matthies C, Pacchetti C, Volkmann J, Isaias IU (2016)
Distinctive neuronal firing patterns in subterritories of the subthalamic nucleus.
Clin Neurophysiol 127(11):3387-3393.

Pritchard RA, Falk L, Larsson M, Leinders M, Sorkin LS (2016)
Different phosphoinositide 3-kinase isoforms mediate carrageenan nociception and inflammation.
Pain 157(1):137-46.

Purrucker JC, Haas K, Rizos T, Khan S, Wolf M, Hennerici MG, Poli S, Kleinschnitz C, Steiner T, Heuschmann PU, Veltkamp R (2016)
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
JAMA Neurol 73(2):169-77.

Purrucker JC, Wolf M, Haas K, Rizos T, Khan S, Dziewas R, Kleinschnitz C, Binder A, Gröschel K, Hennerici MG, Lobotesis K, Poli S, Seidel G, Neumann-Haefelin T, Ringleb PA, Heuschmann PU, Veltkamp R (2016)
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. 
Stroke 47(4):1127-30.

Rattka M, Fluri F, Krsti? M, Asan E, Volkmann J (2016)
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test.
J Vis Exp 111.

Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU (2016)
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
Brain 139(11):2948-2956.

Ritz MF, Grond-Ginsbach C, Kloss M, Tolnay M, Fluri F, Bonati LH, Traenka C, Zeis T, Schaeren-Wiemers N, Peters N, Engelter ST, Lyrer PA (2016)
Identification of Inflammatory, Metabolic, and Cell Survival Pathways Contributing to Cerebral Small Vessel Disease by Postmortem Gene Expression Microarray. 
Curr Neurovasc Res 13(1):58-67.

Rosberg MR, Alvarez S, Klein D, Nielsen FC, Martini R, Levinson SR, Krarup C, Moldovan M (2016)
Progression of motor axon dysfunction and ectopic Nav1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B.
Neurobiol Dis 93:201-14.

Rost NS, Cloonan L, Kanakis AS, Fitzpatrick KM, Azzariti DR, Clarke V, Lourenco CM, Germain DP, Politei JM, Homola GA, Sommer C, Üçeyler N, Sims KB (2016)
Determinants of white matter hyperintensity burden in patients with Fabry disease.
Neurology 86(20):1880-6.

Rovituso DM, Scheffler L, Wunsch M, Kleinschnitz C, Dörck S, Ulzheimer J, Bayas A, Steinman L, Ergün S, Kuerten S (2016)
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
Sci Rep 6:29847.

Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilariño-Güell C (2016)
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
G3 (Bethesda) 6(7):2073-9.

Schneider-Gold C, Krenzer M, Klinker E, Mansouri-Thalegani B, Müllges W, Toyka KV, Gold R (2016)
Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration.
Ther Adv Neurol Disord 9(4):297-303.

Schuhmann MK, Gunreben I, Kleinschnitz C, Kraft P (2016)
Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke.
Int J Mol Sci 17(3):298.

Schuhmann MK, Krstic M, Kleinschnitz C, Fluri F (2016)
Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency. 
Curr Neurovasc Res 13(4):277-282.

Schüle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, Klimpe S, Gallenmüller C, Kurzwelly D, Henkel D, Rimmele F, Stolze H, Kohl Z, Kassubek J, Klockgether T, Vielhaber S, Kamm C, Klopstock T, Bauer P, Züchner S, Liepelt-Scarfone I, Schöls L (2016)
Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients.
Ann Neurol 79(4):646-58.

Schwab N, Schneider-Hohendorf T, Pignolet B, Spadaro M, Görlich D, Meinl I, Windhagen S, Tackenberg B, Breuer J, Cantó E, Kümpfel T, Hohlfeld R, Siffrin V, Luessi F, Posevitz-Fejfár A, Montalban X, Meuth SG, Zipp F, Gold R, Du Pasquier RA, Kleinschnitz C, Jacobi A, Comabella M, Bertolotto A, Brassat D, Wiendl H (2016)
PML risk stratification using anti-JCV antibody index and L-selectin. 
Mult Scler 22(8):1048-60.

Schwarzmaier SM, de Chaumont C, Balbi M, Terpolilli NA, Kleinschnitz C, Gruber A, Plesnila N (2016)
The Formation of Microthrombi in Parenchymal Microvessels after Traumatic Brain Injury Is Independent of Coagulation Factor XI.
J Neurotrauma 33(17):1634-44.

Seger S, Stritt M, Doppler K, Frank S, Panaite A, Kuntzer T, Steck A, Pagenstecher A, Sommer C, Stalder AK (2016)
A semi-automated method to assess intraepidermal nerve fibre density in human skin biopsies. 
Histopathology 68(5):657-65.

Sommer C (2016)
Exploring pain pathophysiology in patients.
Science 354(6312):588-592.

Stangel M, Gold R, Pittrow D, Baumann U, Borte M, Fasshauer M, Hensel M, Huscher D, Reiser M, Sommer C (2016)
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry.
Ther Adv Neurol Disord 9(3):165-79.

Steigerwald F, Müller L, Johannes S, Matthies C, Volkmann J (2016)
Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device.
Mov Disord 31(8):1240-3.

Steinbeck JA, Jaiswal MK, Calder EL, Kishinevsky S, Weishaupt A, Toyka KV, Goldstein PA, Studer L (2016)
Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease.
Cell Stem Cell 18(1):134-43.

Stoll G, Reiners K (2016)
Immune-mediated neuropathies.
Nervenarzt 87(8):887-98.

Üçeyler N, Biko L, Hose D, Hofmann L, Sommer C (2016)
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development.
Mol Pain 12.

Üçeyler N, Necula G, Wagemann E, Toyka KV, Sommer C (2016)
Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy.
Muscle Nerve 53(5):705-10.

Üçeyler N, Schäfer KA, Mackenrodt D, Sommer C, Müllges W (2016)
High-Resolution Ultrasonography of the Superficial Peroneal Motor and Sural Sensory Nerves May Be a Non-invasive Approach to the Diagnosis of Vasculitic Neuropathy.
Front Neurol 7:48.

Üçeyler N, Schröter N, Kafke W, Kramer D, Wanner C, Weidemann F, Sommer C (2016)
Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.
PLoS ONE 11(11):e0166484.

van Eeuwijk JM, Stegner D, Lamb DJ, Kraft P, Beck S, Thielmann I, Kiefer F, Walzog B, Stoll G, Nieswandt B (2016)
The Novel Oral Syk Inhibitor, Bl1002494, Protects Mice From Arterial Thrombosis and Thromboinflammatory Brain Infarction.
Arterioscler Thromb Vasc Biol 36(6):1247-53.

Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W (2016)
Antipsychotics for fibromyalgia in adults.
Cochrane Database Syst Rev 6:CD011804.

Werner C, Pauli M, Doose S, Weishaupt A, Haselmann H, Grünewald B, Sauer M, Heckmann M, Toyka KV, Asan E, Sommer C, Geis C (2016)
Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition.
Brain 139(Pt 2):365-79.

Wilson D, Charidimou A, Ambler G, Fox ZV, Gregoire S, Rayson P, Imaizumi T, Fluri F, Naka H, Horstmann S, Veltkamp R, Rothwell PM, Kwa VI, Thijs V, Lee YS, Kim YD, Huang Y, Wong KS, Jäger HR, Werring DJ (2016)
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysis.
Neurology 87(14):1501-1510.

Wolf K, Braun A, Haining EJ, Tseng YL, Kraft P, Schuhmann MK, Gotru SK, Chen W, Hermanns HM, Stoll G, Lesch KP, Nieswandt B (2016)
Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice.
PLoS ONE 11(1):e0147664.

Yang S, Krug SM, Heitmann J, Hu L, Reinhold AK, Sauer S, Bosten J, Sommer C, Fromm M, Brack A, Rittner HL (2016)
Analgesic drug delivery via recombinant tissue plasminogen activator and microRNA-183-triggered opening of the blood-nerve barrier.
Biomaterials 82:20-33.

Zeller D, Friston KJ, Classen J (2016)
Dynamic causal modeling of touch-evoked potentials in the rubber hand illusion.
Neuroimage 138:266-273.

Biegstraaten M, Arngrímsson R, Barbey F, Boks L, Cecchi F, Deegan PB, Feldt-Rasmussen U, Geberhiwot T, Germain DP, Hendriksz C, Hughes DA, Kantola I, Karabul N, Lavery C, Linthorst GE, Mehta A, van de Mheen E, Oliveira JP, Parini R, Ramaswami U, Rudnicki M, Serra A, Sommer C, Sunder-Plassmann G, Svarstad E, Sweeb A, Terryn W, Tylki-Szymanska A, Tøndel C, Vujkovac B, Weidemann F, Wijburg FA, Woolfson P, Hollak CE (2015)
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.
Orphanet J Rare Dis 10:36.

Bittner S, Bobak N, Hofmann MS, Schuhmann MK, Ruck T, Göbel K, Brück W, Wiendl H, Meuth SG (2015)
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Int J Mol Sci 16(8):16880-96.

Bronstein JM, Tagliati M, McIntyre C, Chen R, Cheung T, Hargreaves EL, Israel Z, Moffitt M, Montgomery EB, Stypulkowski P, Shils J, Denison T, Vitek J, Volkman J, Wertheimer J, Okun MS (2015)
The rationale driving the evolution of deep brain stimulation to constant-current devices.
Neuromodulation 18(2):85-8; discussion 88-9.

Brüggemann N, Kühn A, Schneider SA, Kamm C, Wolters A, Krause P, Moro E, Steigerwald F, Wittstock M, Tronnier V, Lozano AM, Hamani C, Poon YY, Zittel S, Wächter T, Deuschl G, Krüger R, Kupsch A, Münchau A, Lohmann K, Volkmann J, Klein C (2015)
Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. 
Neurology 84(9):895-903.

Cherpokova D, Bender M, Morowski M, Kraft P, Schuhmann MK, Akbar SM, Sultan CS, Hughes CE, Kleinschnitz C, Stoll G, Dragone LL, Watson SP, Tomlinson MG, Nieswandt B (2015)
SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice. 
Blood 125(1):185-94.

Coenen VA, Amtage F, Volkmann J, Schläpfer TE (2015)
Deep Brain Stimulation in Neurological and Psychiatric Disorders.
Dtsch Arztebl Int 112(31-32):519-26.

Devanathan V, Hagedorn I, Köhler D, Pexa K, Cherpokova D, Kraft P, Singh M, Rosenberger P, Stoll G, Birnbaumer L, Piekorz RP, Beer-Hammer S, Nieswandt B, Nürnberg B (2015)
Platelet Gi protein G?i2 is an essential mediator of thrombo-inflammatory organ damage in mice.
Proc Natl Acad Sci U S A 112(20):6491-6.

Dietz L, Frommer F, Vogel AL, Vaeth M, Serfling E, Waisman A, Buttmann M, Berberich-Siebelt F (2015)
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms. 
Eur J Immunol 45(5):1377-89.

Dinkelbach L, Mueller J, Poewe W, Delazer M, Elben S, Wolters A, Karner E, Wittstock M, Benecke R, Schnitzler A, Volkmann J, Südmeyer M (2015)
Cognitive outcome of pallidal deep brain stimulation for primary cervical dystonia: One year follow up results of a prospective multicenter trial. 
Parkinsonism Relat Disord 21(8):976-80.

Doppler K, Appeltshauser L, Krämer HH, Ng JK, Meinl E, Villmann C, Brophy P, Dib-Hajj SD, Waxman SG, Weishaupt A, Sommer C (2015)
Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.
PLoS ONE 10(7):e0134274.

Doppler K, Appeltshauser L, Wilhelmi K, Villmann C, Dib-Hajj SD, Waxman SG, Mäurer M, Weishaupt A, Sommer C (2015)
Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. 
J Neurol Neurosurg Psychiatry 86(7):720-8.

Doppler K, Reiners K (2015)
Diabetic neuropathy: do not only consider distal symmetrical neuropathy.
Nervenarzt 86(2):161-6.

Doppler K, Rittner HL, Deckart M, Sommer C (2015)
Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia.
Pain 156(11):2319-25.

Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C (2015) 
Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. 
Mov Disord 30(12):1688-92.

Fluri F, Bieber M, Volkmann J, Kleinschnitz C (2015)
Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation.
J Vis Exp na(104):e53066-e53066.

Fluri F, Grünstein D, Cam E, Ungethuem U, Hatz F, Schäfer J, Samnick S, Israel I, Kleinschnitz C, Orts-Gil G, Moch H, Zeis T, Schaeren-Wiemers N, Seeberger P (2015)
Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.
Exp Neurol 265:142-51.

Fluri F, Schuhmann MK, Kleinschnitz C (2015)
Animal models of ischemic stroke and their application in clinical research.
Drug Des Devel Ther 9:3445-54.

Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV (2015)
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.
Exp Neurol 265:8-21.

Gelderblom M, Sobey CG, Kleinschnitz C, Magnus T (2015)
Danger signals in stroke.
Ageing Res Rev 24(Pt A):77-82.

Göb E, Bittner S, Bobak N, Kraft P, Göbel K, Langhauser F, Homola GA, Brede M, Budde T, Meuth SG, Kleinschnitz C (2015)
The two-pore domain potassium channel KCNK5 deteriorates outcome in ischemic neurodegeneration.
Pflugers Arch 467(5):973-87.

Göb E, Reymann S, Langhauser F, Schuhmann MK, Kraft P, Thielmann I, Göbel K, Brede M, Homola G, Solymosi L, Stoll G, Geis C, Meuth SG, Nieswandt B, Kleinschnitz C (2015)
Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation.
Ann Neurol 77(5):784-803.

Groh J, Klein I, Hollmann C, Wettmarshausen J, Klein D, Martini R (2015)
CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice. 
Glia 63(6):977-86.

Gulberti A, Moll CK, Hamel W, Buhmann C, Koeppen JA, Boelmans K, Zittel S, Gerloff C, Westphal M, Schneider TR, Engel AK(2015)
Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus. 
Neuroimage Clin 9:436-49.

Gutknecht L, Popp S, Waider J, Sommerlandt FM, Göppner C, Post A, Reif A, van den Hove D, Strekalova T, Schmitt A, Cola?o MB, Sommer C, Palme R, Lesch KP (2015)
Interaction of brain 5-HT synthesis deficiency, chronic stress and sex differentially impact emotional behavior in Tph2 knockout mice. 
Psychopharmacology (Berl) 232(14):2429-41.

Haarmann A, Nehen M, Deiß A, Buttmann M (2015)
Fumaric Acid Esters Do Not Reduce Inflammatory NF-?B/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Int J Mol Sci 16(8):19086-95.

Haarmann A, Nowak E, Deiß A, van der Pol S, Monoranu CM, Kooij G, Müller N, van der Valk P, Stoll G, de Vries HE, Berberich-Siebelt F, Buttmann M (2015)
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin ?-4-transduced outside-in signalling.
Acta Neuropathol (Berl) 129(5):639-52.

Hansen N, Kahn AK, Zeller D, Katsarava Z, Sommer C, Üçeyler N (2015)
Amplitudes of Pain-Related Evoked Potentials Are Useful to Detect Small Fiber Involvement in Painful Mixed Fiber Neuropathies in Addition to Quantitative Sensory Testing - An Electrophysiological Study.
Front Neurol 6:244.

Hartmann CJ, Wojtecki L, Vesper J, Volkmann J, Groiss SJ, Schnitzler A, Südmeyer M (2015)
Long-term evaluation of impedance levels and clinical development in subthalamic deep brain stimulation for Parkinson's disease.
Parkinsonism Relat Disord 21(10):1247-50.

Heussinger N, Kontopantelis E, Gburek-Augustat J, Jenke A, Vollrath G, Korinthenberg R, Hofstetter P, Meyer S, Brecht I, Kornek B, Herkenrath P, Schimmel M, Wenner K, Häusler M, Lutz S, Karenfort M, Blaschek A, Smitka M, Karch S, Piepkorn M, Rostasy K, Lücke T, Weber P, Trollmann R, Klepper J, Häussler M, Hofmann R, Weissert R, Merkenschlager A, Buttmann M, for GRACE-MS (German-speaking Research Alliance for ChildrEn with Multiple Sclerosis) (2015)
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Ann Neurol 77(6):1076-82.

Hopfner F, Stevanin G, Müller SH, Mundwiller E, Bungeroth M, Durr A, Pendziwiat M, Anheim M, Schneider SA, Tittmann L, Klebe S, Lorenz D, Deuschl G, Brice A, Kuhlenbäumer G (2015)
The impact of rare variants in FUS in essential tremor.
Mov Disord 30(5):721-4.

Ip CW, Beck SK, Volkmann J (2015)
Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.
J Neural Transm 122(12):1633-43.

Kippnich M, Lotz C, Kredel M, Schimmer C, Weismann D, Sommer C, Kranke P, Roewer N, Muellenbach RM (2015)
Venoarterial extracorporeal membrane oxygenation for out-of-hospital cardiac arrest. Case series of prehospital and in-hospital therapies.
Anaesthesist 64(8):580-5.

Klebe S, Stevanin G, Depienne C (2015)
Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting.
Rev Neurol (Paris) 171(6-7):505-30.

Kleikers PW, Hooijmans C, Göb E, Langhauser F, Rewell SS, Radermacher K, Ritskes-Hoitinga M, Howells DW, Kleinschnitz C, Schmidt HH (2015)
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation.
Sci Rep 5:13428.

Klein D, Groh J, Weishaupt A, Martini R (2015)
Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B.
J Neuroinflammation 12:49.

Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R (2015)
Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Brain 138(Pt 11):3193-205.

Kleinschnitz C, Niemczyk G, Rehberg-Weber K, Wernsdörfer C (2015)
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Int J Mol Sci 16(7):15271-86.

Kraft P, Drechsler C, Gunreben I, Heuschmann PU, Kleinschnitz C (2015)
Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
PLoS ONE 10(3):e0119810.

Kraft P, Drechsler C, Schuhmann MK, Gunreben I, Kleinschnitz C (2015)
Characterization of Peripheral Immune Cell Subsets in Patients with Acute and Chronic Cerebrovascular Disease: A Case-Control Study. 
Int J Mol Sci 16(10):25433-49.

Kraft P, Schuhmann MK, Fluri F, Lorenz K, Zernecke A, Stoll G, Nieswandt B, Kleinschnitz C (2015)
Efficacy and Safety of Platelet Glycoprotein Receptor Blockade in Aged and Comorbid Mice With Acute Experimental Stroke.
Stroke 46(12):3502-6.

Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, Flechsenhar J, Neugebauer H, Jüttler E, Grau A, Palm F, Röther J, Michels P, Hamann GF, Hüwel J, Hagemann G, Barber B, Terborg C, Trostdorf F, Bäzner H, Roth A, Wöhrle J, Keller M, Schwarz M, Reimann G, Volkmann J, Müllges W, Kraft P, Classen J, Hobohm C, Horn M, Milewski A, Reichmann H, Schneider H, Schimmel E, Fink GR, Dohmen C, Stetefeld H, Witte O, Günther A, Neumann-Haefelin T, Racs AE, Nueckel M, Erbguth F, Kloska SP, Dörfler A, Köhrmann M, Schwab S, Huttner HB (2015)
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
JAMA 313(8):824-36.

Lemmer S, Schießer P, Geis C, Sommer C, Vanegas H, Üçeyler N (2015)
Enhanced spinal neuronal responses as a mechanism for the increased nociceptive sensitivity of interleukin-4 deficient mice.
Exp Neurol 271:198-204.

Liesz A, Hu X, Kleinschnitz C, Offner H (2015)
Functional role of regulatory lymphocytes in stroke: facts and controversies.
Stroke 46(5):1422-30.

Lill CM, Luessi F, Alcina A, Sokolova EA, Ugidos N, de la Hera B, Guillot-Noël L, Malhotra S, Reinthaler E, Schjeide BM, Mescheriakova JY, Mashychev A, Wohlers I, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Astobiza I, Blaschke P, Boyko AN, Buttmann M, Chan A, Dörner T, Epplen JT, Favorova OO, Fedetz M, Fernández O, García-Martínez A, Gerdes LA, Graetz C, Hartung HP, Hoffjan S, Izquierdo G, Korobko DS, Kroner A, Kubisch C, Kümpfel T, Leyva L, Lohse P, Malkova NA, Montalban X, Popova EV, Rieckmann P, Rozhdestvenskii AS, Schmied C, Smagina IV, Tsareva EY, Winkelmann A, Zettl UK, Binder H, Cournu-Rebeix I, Hintzen R, Zimprich A, Comabella M, Fontaine B, Urcelay E, Vandenbroeck K, Filipenko M, Matesanz F, Zipp F, Bertram L (2015)
Genome-wide significant association with seven novel multiple sclerosis risk loci.
J Med Genet 52(12):848-55.

Linker R, Kallmann BA, Kleinschnitz C, Rieckmann P, Mäurer M, Schwab S (2015)
"Time is brain" in relapsing remitting multiple sclerosis. Current treatment concepts in immunotherapy.
Nervenarzt 86(12):1528-37.

Luger S, Hohmann C, Niemann D, Kraft P, Gunreben I, Neumann-Haefelin T, Kleinschnitz C, Steinmetz H, Foerch C, Pfeilschifter W (2015)
Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants.
Patient Prefer Adherence 9:1695-705.

Magg B, Riegler C, Wiedmann S, Heuschmann P, Sommer C, Üçeyler N (2015)
Self-administered version of the Fabry-associated pain questionnaire for adult patients.
Orphanet J Rare Dis 10:113.

Maier C, Baron R, Sommer C (2015)
Neuropathic pain. How to open the blackbox.
Schmerz 29(5):479-80, 482-5.

Martinez V, Üçeyler N, Ben Ammar S, Alvarez JC, Gaudot F, Sommer C, Bouhassira D, Fletcher D (2015)
Clinical, histological, and biochemical predictors of postsurgical neuropathic pain.
Pain 156(11):2390-8.

Martinez-Martin P, Reddy P, Katzenschlager R, Antonini A, Todorova A, Odin P, Henriksen T, Martin A, Calandrella D, Rizos A, Bryndum N, Glad A, Dafsari HS, Timmermann L, Ebersbach G, Kramberger MG, Samuel M, Wenzel K, Tomantschger V, Storch A, Reichmann H, Pirtosek Z, Trost M, Svenningsson P, Palhagen S, Volkmann J, Chaudhuri KR (2015)
EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
Mov Disord 30(4):510-6.

Mezger M, Göbel K, Kraft P, Meuth SG, Kleinschnitz C, Langer HF (2015)
Platelets and vascular inflammation of the brain.
Hamostaseologie 35(3):244-51.

Meziane HB, Moisello C, Perfetti B, Kvint S, Isaias IU, Quartarone A, Di Rocco A, Ghilardi MF (2015)
Movement preparation and bilateral modulation of beta activity in aging and Parkinson's disease. 
PLoS ONE 10(1):e0114817.

Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, Poppiti RJ, Bockelman B, Keyvani K, Pollak L, Mendlovic S, Fowkes M, Eberhart CG, Buttmann M, Toyka KV, Meyer-Ter-Vehn T, Petursdottir V, Gilden D (2015)
Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. 
JAMA Neurol 72(11):1281-7.

Odin P, Ray Chaudhuri K, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P, Krauss JK, Henriksen T, Katzenschlager R, Antonini A, Rascol O, Poewe W, National Steering Committees , Brücke T, Pirker W, Ransmayr G, Schwingenschuh P, Tomantschger V, Volc D, Jespersen H, Kamal A, Karlsborg M, Oppel L, Pedersen S, Avikainen S, Kaasinen V, Pekkonen E, Ruottinen H, Azulay JP, Corvol JC, Courbon CB, Defebvre L, Durif F, Houeto JL, Krack P, Tison F, Andrich J, Ehret R, Klostermann F, Kruger R, Lingor P, Liszka R, Schwarz J, Timmermann L, Warnecke T, Bostantjopoulou S, Konitsiotis S, Papageorgiou S, Stathishens P, Stefanis L, Zikos P, Browne P, Healy D, Lynch T, O'Riordan S, O'Sullivan S, Walsh R, Abbruzzese G, Lopiano L, Modugno N, Tamma F, Holmberg B, Linder J, Nyholm D, Pålhagen S, Arbelo JM, Bana RY, Castrillo JC, Castro A, Espiga PJ, Kulisevsky J, Lezcano E, Luquín R, Mir P, Puente V, Valldeoriola F, Burn D, Clarke C, Foltynie T, Grosset D, Hindle J, Leake A, Lees A, Morris H, Stewart D, Walker R, Worth P (2015)
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
Parkinsonism Relat Disord 21(10):1133-44.

Petzke F, Welsch P, Klose P, Schaefert R, Sommer C, Häuser W (2015)
Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Schmerz 29(1):60-72.

Pötter-Nerger M, Govender S, Deuschl G, Volkmann J, Colebatch JG (2015)
Selective changes of ocular vestibular myogenic potentials in Parkinson's disease.
Mov Disord 30(4):584-9.

Pyatigorskaya N, Sharman M, Corvol JC, Valabregue R, Yahia-Cherif L, Poupon F, Cormier-Dequaire F, Siebner H, Klebe S, Vidailhet M, Brice A, Lehéricy S (2015)
High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. 
Mov Disord 30(8):1077-84.

Rovituso DM, Duffy CE, Schroeter M, Kaiser CC, Kleinschnitz C, Bayas A, Elsner R, Kuerten S (2015)
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Sci Rep 5:14265.

Ruck T, Bittner S, Afzali AM, Göbel K, Glumm S, Kraft P, Sommer C, Kleinschnitz C, Preuße C, Stenzel W, Wiendl H, Meuth SG (2015)
The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies.
Oncotarget 6(41):43230-43.

Schaefert R, Welsch P, Klose P, Sommer C, Petzke F, Häuser W (2015)
Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
Schmerz 29(1):47-59.

Scheytt S, Riediger N, Braunsdorf S, Sommer C, Üçeyler N (2015)
Increased gene expression of growth associated protein-43 in skin of patients with early-stage peripheral neuropathies.
J Neurol Sci 355(1-2):131-7.

Schleicher RI, Reichenbach F, Kraft P, Kumar A, Lescan M, Todt F, Göbel K, Hilgendorf I, Geisler T, Bauer A, Olbrich M, Schaller M, Wesselborg S, O'Reilly L, Meuth SG, Schulze-Osthoff K, Gawaz M, Li X, Kleinschnitz C, Edlich F, Langer HF (2015)
Platelets induce apoptosis via membrane-bound FasL. 
Blood 126(12):1483-93.

Schrewe L, Lill CM, Liu T, Salmen A, Gerdes LA, Guillot-Noel L, Akkad DA, Blaschke P, Graetz C, Hoffjan S, Kroner A, Demir S, Böhme A, Rieckmann P, ElAli A, Hagemann N, Hermann DM, Cournu-Rebeix I, Zipp F, Kümpfel T, Buttmann M, Zettl UK, Fontaine B, Bertram L, Gold R, Chan A (2015)
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS. 
J Neuroinflammation 12:234.

Schuhmann MK, Bittner S, Meuth SG, Kleinschnitz C, Fluri F (2015)
Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Int J Mol Sci 16(12):29454-66.

Schuhmann MK, Kraft P, Stoll G, Lorenz K, Meuth SG, Wiendl H, Nieswandt B, Sparwasser T, Beyersdorf N, Kerkau T, Kleinschnitz C (2015)
CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke. 
J Cereb Blood Flow Metab 35(1):6-10.

Simon CM, Rauskolb S, Gunnersen JM, Holtmann B, Drepper C, Dombert B, Braga M, Wiese S, Jablonka S, Pühringer D, Zielasek J, Hoeflich A, Silani V, Wolf E, Kneitz S, Sommer C, Toyka KV, Sendtner M (2015) 
Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy. 
Acta Neuropathol (Berl) 130(3):373-87.

Sommer C, Welsch P, Klose P, Schaefert R, Petzke F, Häuser W (2015)
Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
Schmerz 29(1):35-46.

Strickland AV, Schabhüttl M, Offenbacher H, Synofzik M, Hauser NS, Brunner-Krainz M, Gruber-Sedlmayr U, Moore SA, Windhager R, Bender B, Harms M, Klebe S, Young P, Kennerson M, Garcia AS, Gonzalez MA, Züchner S, Schule R, Shy ME, Auer-Grumbach M (2015)
Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1.
J Neurol 262(9):2124-34.

Üçeyler N, Geng A, Reiners K, Toyka KV, Sommer C (2015)
Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients.
J Neurol 262(9):2092-100.

Üçeyler N, Riediger N, Kafke W, Sommer C (2015)
Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies.
J Neurol 262(1):203-12.

Üçeyler N, Sommer C (2015)
Fibromyalgia syndrome: A disease of the small nerve fibers?.
Z Rheumatol 74(6):490-2, 494-5.

Üçeyler N, Zeller J, Kewenig S, Kittel-Schneider S, Fallgatter AJ, Sommer C (2015)
Increased cortical activation upon painful stimulation in fibromyalgia syndrome.
BMC Neurol 15:210.

Verhenne S, Denorme F, Libbrecht S, Vandenbulcke A, Pareyn I, Deckmyn H, Lambrecht A, Nieswandt B, Kleinschnitz C, Vanhoorelbeke K, De Meyer SF (2015)
Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice.
Blood 126(14):1715-22.

Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, Wattjes MP, Svenningsson A, Olsson T, Hartung HP, Hermsen D, Tumani H, Adams O, Kieseier BC (2015)
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Mult Scler 21(8):1036-44.

Weidemann F, Liu D, Hu K, Florescu C, Niemann M, Herrmann S, Kramer B, Klebe S, Doppler K, Üçeyler N, Ritter CO, Ertl G, Störk S (2015)
The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement.
Int J Cardiol 194:50-7.

Weishaupt A, Paulsen D, Werner S, Wolf N, Köllner G, Rübsamen-Schaeff H, Hünig T, Kerkau T, Beyersdorf N (2015)
The T cell-selective IL-2 mutant AIC284 mediates protection in a rat model of Multiple Sclerosis.
J Neuroimmunol 282:63-72.

Weiss PH, Herzog J, Pötter-Nerger M, Falk D, Herzog H, Deuschl G, Volkmann J, Fink GR (2015)
Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers.
Mov Disord 30(8):1121-5.

Welsch P, Sommer C, Schiltenwolf M, Häuser W (2015)
Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week.
Schmerz 29(1):85-95.

Werner C, Haselmann H, Weishaupt A, Toyka KV, Sommer C, Geis C (2015)
Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms.
J Neural Transm 122(3):357-62.

Zeller D, Litvak V, Friston KJ, Classen J (2015)
Sensory processing and the rubber hand illusion--an evoked potentials study.
J Cogn Neurosci 27(3):573-82.

Ziegler D, Strom A, Lobmann R, Reiners K, Rett K, Schnell O (2015)
High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study). 
J Diabetes Complications 29(8):998-1002.

Adamchic I, Hauptmann C, Barnikol UB, Pawelczyk N, Popovych O, Barnikol TT, Silchenko A, Volkmann J, Deuschl G, Meissner WG, Maarouf M, Sturm V, Freund HJ, Tass PA (2014)
Coordinated reset neuromodulation for Parkinson's disease: proof-of-concept study.
Mov Disord 29(13):1679-84.

Albert-Weissenberger C, Mencl S, Hopp S, Kleinschnitz C, Sirén AL (2014)
Role of the kallikrein-kinin system in traumatic brain injury.
Front Cell Neurosci 8:345.

Albert-Weissenberger C, Mencl S, Schuhmann MK, Salur I, Göb E, Langhauser F, Hopp S, Hennig N, Meuth SG, Nolte MW, Sirén AL, Kleinschnitz C (2014)
C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation. 
Front Cell Neurosci 8:269.

Bekircan-Kurt CE, Uçeyler N, Sommer C (2014)
Cutaneous activation of rage in nonsystemic vasculitic and diabetic neuropathy.
Muscle Nerve 50(3):377-83.

Bischoff JM, Ringsted TK, Petersen M, Sommer C, Uçeyler N, Werner MU (2014)
A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial.
PLoS ONE 9(10):e109144.

Bittner S, Ruck T, Göbel K, Henschel C, Afzali AM, Göb E, Müntefering T, Kleinschnitz C, Wiendl H, Meuth SG (2014)
Effects of glatiramer acetate in a spontaneous model of autoimmune neuroinflammation.
Am J Pathol 184(7):2056-65.

Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA (2014)
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. 
Lancet Neurol 13(8):795-806.

Chuang WY, Ströbel P, Bohlender-Willke AL, Rieckmann P, Nix W, Schalke B, Gold R, Opitz A, Klinker E, Inoue M, Müller-Hermelink HK, Saruhan-Direskeneli G, Bugert P, Willcox N, Marx A (2014)
Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
J Autoimmun 52:122-9.

Cruccu G, Pennisi EM, Antonini G, Biasiotta A, di Stefano G, La Cesa S, Leone C, Raffa S, Sommer C, Truini A (2014)
Trigeminal isolated sensory neuropathy (TISN) and FOSMN syndrome: despite a dissimilar disease course do they share common pathophysiological mechanisms?
BMC Neurol 14:248.

Doppler K, Ebert S, Uçeyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C (2014)
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.
Acta Neuropathol (Berl) 128(1):99-109.

Estrada V, Brazda N, Schmitz C, Heller S, Blazyca H, Martini R, Müller HW (2014)
Long-lasting significant functional improvement in chronic severe spinal cord injury following scar resection and polyethylene glycol implantation.
Neurobiol Dis 67:165-79.

Gelderblom M, Melzer N, Schattling B, Göb E, Hicking G, Arunachalam P, Bittner S, Ufer F, Herrmann AM, Bernreuther C, Glatzel M, Gerloff C, Kleinschnitz C, Meuth SG, Friese MA, Magnus T (2014)
Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke.
Stroke 45(11):3395-402.

Giordano R, Canesi M, Isalberti M, Isaias IU, Montemurro T, Viganò M, Montelatici E, Boldrin V, Benti R, Cortelezzi A, Fracchiolla N, Lazzari L, Pezzoli G (2014)
Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.
J Transl Med 12:14.

Göbel K, Schuhmann MK, Pankratz S, Stegner D, Herrmann AM, Braun A, Breuer J, Bittner S, Ruck T, Wiendl H, Kleinschnitz C, Nieswandt B, Meuth SG (2014)
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis. 
Eur J Immunol 44(8):2295-305.

Gomez-Mancilla B, Brand R, Jürgens TP, Göbel H, Sommer C, Straube A, Evers S, Sommer M, Campos V, Kalkman HO, Hariry S, Pezous N, Johns D, Diener HC, BGG492 Study Group (2014)
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
Cephalalgia 34(2):103-13.

Gröne E, Üçeyler N, Abahji T, Fleckenstein J, Irnich D, Mussack T, Hoffmann U, Sommer C, Lang PM (2014)
Reduced intraepidermal nerve fiber density in patients with chronic ischemic pain in peripheral arterial disease.
Pain 155(9):1784-92.

Groppa S, Herzog J, Falk D, Riedel C, Deuschl G, Volkmann J. (2014) Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor. Brain 137(Pt 1):109-21.

Harrer JU, Uçeyler N, Doppler K, Fischer TZ, Dib-Hajj SD, Waxman SG, Sommer C (2014)
Neuropathic pain in two-generation twins carrying the sodium channel Nav1.7 functional variant R1150W.
Pain 155(10):2199-203.

Häuser W, Walitt B, Fitzcharles MA, Sommer C (2014)
Review of pharmacological therapies in fibromyalgia syndrome.
Arthritis Res Ther 16(1):201.

He L, Uçeyler N, Krämer HH, Colaço MN, Lu B, Birklein F, Sommer C (2014)
Methylprednisolone prevents nerve injury-induced hyperalgesia in neprilysin knockout mice.
Pain 155(3):574-80.

Isaias IU, Dipaola M, Michi M, Marzegan A, Volkmann J, Rodocanachi Roidi ML, Frigo CA, Cavallari P (2014)
Gait initiation in children with Rett syndrome.
PLoS ONE 9(4):e92736.

Isaias IU, Spiegel J, Brumberg J, Cosgrove KP, Marotta G, Oishi N, Higuchi T, Küsters S, Schiller M, Dillmann U, van Dyck CH, Buck A, Herrmann K, Schloegl S, Volkmann J, Lassmann M, Fassbender K, Lorenz R, Samnick S (2014)
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.
Front Aging Neurosci 6:213.

Klein D, Groh J, Wettmarshausen J, Martini R (2014)
Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulation.
Glia 62(5):736-50.

Kraft P, Drechsler C, Gunreben I, Heuschmann PU, Kleinschnitz C (2014)
Regulation of blood coagulation factors XI and XII in patients with acute and chronic cerebrovascular disease: a case-control study.
Cerebrovasc Dis 38(5):337-43.

Kraft P, Drechsler C, Gunreben I, Nieswandt B, Stoll G, Heuschmann PU, Kleinschnitz C. (2014) Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study. PLoS ONE 9(6):e99851.

Krieger F, Elflein N, Saenger S, Wirthgen E, Rak K, Frantz S, Hoeflich A, Toyka KV, Metzger F, Jablonka S (2014)
Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.
Brain 137(Pt 5):1374-93.

Langhauser F, Kraft P, Göb E, Leinweber J, Schuhmann MK, Lorenz K, Gelderblom M, Bittner S, Meuth SG, Wiendl H, Magnus T, Kleinschnitz C (2014)
Blocking of ?4 integrin does not protect from acute ischemic stroke in mice. 
Stroke 45(6):1799-806.

Lill CM, Schilling M, Ansaloni S, Schröder J, Jaedicke M, Luessi F, Schjeide BM, Mashychev A, Graetz C, Akkad DA, Gerdes LA, Kroner A, Blaschke P, Hoffjan S, Winkelmann A, Dörner T, Rieckmann P, Steinhagen-Thiessen E, Lindenberger U, Chan A, Hartung HP, Aktas O, Lohse P, Buttmann M, Kümpfel T, Kubisch C, Zettl UK, Epplen JT, Zipp F, Bertram L (2014)
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
Neurogenetics 15(2):129-34.

Luger S, Hohmann C, Kraft P, Halmer R, Gunreben I, Neumann-Haefelin T, Kleinschnitz C, Walter S, Haripyan V, Steinmetz H, Foerch C, Pfeilschifter W (2014)
Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation. 
Int J Stroke 9(5):569-75.

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J, Stamelou M, Pittman AM, Noyce AJ, Mok KY, Opladen T, Kunstmann E, Hodecker S, Münchau A, Volkmann J, Samnick S, Sidle K, Nanji T, Sweeney MG, Houlden H, Batla A, Zecchinelli AL, Pezzoli G, Marotta G, Lees A, Alegria P, Krack P, Cormier-Dequaire F, Lesage S, Brice A, Heutink P, Gasser T, Lubbe SJ, Morris HR, Taba P, Koks S, Majounie E, Raphael Gibbs J, Singleton A, Hardy J, Klebe S, Bhatia KP, Wood NW, International
Parkinson's Disease Genomics Consortium and UCL-exomes consortium (2014) Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Brain 137(Pt 9):2480-92.

Mencl S, Hennig N, Hopp S, Schuhmann MK, Albert-Weissenberger C, Sirén AL, Kleinschnitz C (2014)
FTY720 does not protect from traumatic brain injury in mice despite reducing posttraumatic inflammation. 
J Neuroimmunol 274(1-2):125-31.

Méneret A, Depienne C, Riant F, Trouillard O, Bouteiller D, Cincotta M, Bitoun P, Wickert J, Lagroua I, Westenberger A, Borgheresi A, Doummar D, Romano M, Rossi S, Defebvre L, De Meirleir L, Espay AJ, Fiori S, Klebe S, Quélin C, Rudnik-Schöneborn S, Plessis G, Dale RC, Sklower Brooks S, Dziezyc K, Pollak P, Golmard JL, Vidailhet M, Brice A, Roze E (2014)
Congenital mirror movements: mutational analysis of RAD51 and DCC in 26 cases.
Neurology 82(22):1999-2002.

Meyer zu Hörste G, Cordes S, Mausberg AK, Zozulya AL, Wessig C, Sparwasser T, Mathys C, Wiendl H, Hartung HP, Kieseier BC (2014) 
FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.
PLoS ONE 9(10):e108756.

Niemann A, Huber N, Wagner KM, Somandin C, Horn M, Lebrun-Julien F, Angst B, Pereira JA, Halfter H, Welzl H, Feltri ML, Wrabetz L, Young P, Wessig C, Toyka KV, Suter U (2014)
The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease.
Brain 137(Pt 3):668-82.

Norrmén C, Figlia G, Lebrun-Julien F, Pereira JA, Trötzmüller M, Köfeler HC, Rantanen V, Wessig C, van Deijk AL, Smit AB, Verheijen MH, Rüegg MA, Hall MN, Suter U (2014)
mTORC1 controls PNS myelination along the mTORC1-RXR?-SREBP-lipid biosynthesis axis in Schwann cells.
Cell Rep 9(2):646-60.

Nowicki M, Baum P, Kosacka J, Stockinger M, Klöting N, Blüher M, Bechmann I, Toyka KV (2014)
Effects of isoflurane anesthesia on F-waves in the sciatic nerve of the adult rat.
Muscle Nerve 50(2):257-61.

Pankratz S, Bittner S, Herrmann AM, Schuhmann MK, Ruck T, Meuth SG, Wiendl H (2014)
Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo. 
FASEB J 28(8):3435-45.

Real RG, Herbert C, Kotchoubey B, Wessig C, Volkmann J, Kübler A (2014)
Psychophysiological correlates of coping and quality of life in patients with ALS.
Clin Neurophysiol 125(5):955-61.

Reese R, Knudsen K, Falk D, Mehdorn HM, Deuschl G, Volkmann J (2014)
Motor outcome of dystonic camptocormia treated with pallidal neurostimulation.
Parkinsonism Relat Disord 20(2):176-9.

Reich MM, Volkmann J (2014)
Deep brain stimulation for hyperkinetic movement disorders.
Nervenarzt 85(2):147-55.

Rovituso D, Heller S, Schroeter M, Kleinschnitz C, Kuerten S (2014)
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
J Neuroimmunol 272(1-2):86-90.

Sauer RS, Krug SM, Hackel D, Staat C, Konasin N, Yang S, Niedermirtl B, Bosten J, Günther R, Dabrowski S, Doppler K, Sommer C, Blasig IE, Brack A, Rittner HL (2014)
Safety, efficacy, and molecular mechanism of claudin-1-specific peptides to enhance blood-nerve-barrier permeability.
J Control Release 185:88-98.

Schläpfer T, Volkmann J, Deuschl G (2014)
Deep brain stimulation in neurology and psychiatry.
Nervenarzt 85(2):135-6.

Sommer C, Birklein F (2014)
The complex regional pain syndrome.
Fortschr Neurol Psychiatr 82(2):104-15.

Sommer C (2014)
Sural nerve biopsy for unclear polyneuropathy.
For. Nervenarzt 85(8):1016-7.

Üçeyler N, Ganendiran S, Kramer D, Sommer C (2014)
Characterization of pain in fabry disease.
Clin J Pain 30(10):915-20.

Uçeyler N, Homola GA, Guerrero González H, Kramer D, Wanner C, Weidemann F, Solymosi L, Sommer C (2014) 
Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease.
PLoS ONE 9(1):e87054.

Üçeyler N, Kewenig S, Kafke W, Kittel-Schneider S, Sommer C (2014)
Skin cytokine expression in patients with fibromyalgia syndrome is not different from controls.
BMC Neurol 14(1):185.

Üçeyler N, Magg B, Thomas P, Wiedmann S, Heuschmann P, Sommer C (2014)
A comprehensive Fabry-related pain questionnaire for adult patients.
Pain 155(11):2301-5.

Üçeyler N, Valet M, Kafke W, Tölle TR, Sommer C (2014)
Local and systemic cytokine expression in patients with postherpetic neuralgia.
PLoS ONE 9(8):e105269.

Volkmann J, Mueller J, Deuschl G, Kühn AA, Krauss JK, Poewe W, Timmermann L, Falk D, Kupsch A, Kivi A, Schneider GH, Schnitzler A, Südmeyer M, Voges J, Wolters A, Wittstock M, Müller JU, Hering S, Eisner W, Vesper J, Prokop T, Pinsker M, Schrader C, Kloss M, Kiening K, Boetzel K, Mehrkens J, Skogseid IM, Ramm-Pettersen J, Kemmler G, Bhatia KP, Vitek JL, Benecke R, DBS study group for dystonia (2014)
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.
Lancet Neurol 13(9):875-84.

Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O (2014)
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. 
Ann Neurol 76(6):792-801.

Weidemann F, Krämer J, Duning T, Lenders M, Canaan-Kühl S, Krebs A, Guerrero González H, Sommer C, Üçeyler N, Niemann M, Störk S, Schelleckes M, Reiermann S, Stypmann J, Brand SM, Wanner C, Brand E (2014)
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. 
J Am Soc Nephrol 25(4):837-49.

Zeller D, Classen J (2014)
Plasticity of the motor system in multiple sclerosis.
Neuroscience 283:222-30.

Ablin J, Fitzcharles MA, Buskila D, Shir Y, Sommer C, Häuser W (2013)
Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies.
Evid Based Complement Alternat Med 2013:485272.

Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A (2013)
Dystonia rating scales: critique and recommendations.
Mov Disord 28(7):874-83. 

Albert-Weißenberger C, Sirén AL, Kleinschnitz C (2013)
Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system.
Prog Neurobiol 101-102:65-82.

Andronic J, Bobak N, Bittner S, Ehling P, Kleinschnitz C, Herrmann AM, Zimmermann H, Sauer M, Wiendl H, Budde T, Meuth SG, Sukhorukov VL (2013)
Identification of two-pore domain potassium channels as potent modulators of osmotic volume regulation in human T lymphocytes. 
BBA - BIOMEMBRANES 1828(2):699-707.

Bischoff JM, Petersen M, Uçeyler N, Sommer C, Kehlet H, Werner MU (2013)
Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial.
Anesthesiology 119 (6):1444-52.

Bittner S, Ruck T, Schuhmann MK, Herrmann AM, Moha ou Maati H, Bobak N, Göbel K, Langhauser F, Stegner D, Ehling P, Borsotto M, Pape HC, Nieswandt B, Kleinschnitz C, Heurteaux C, Galla HJ, Budde T, Wiendl H, Meuth SG (2013)
Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.
Nat Med 19(9):1161-5.

Buttmann M, Kaveri S, Hartung HP (2013)
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
Trends Pharmacol Sci 34(8):445-57.

Buttmann M, Metz I, Brecht I, Brück W, Warmuth-Metz M (2013)
Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case report.
J Neurol Sci 324(1-2):183-6.

Camara M, Beyersdorf N, Fischer HJ, Herold MJ, Ip CW, van den Brandt J, Toyka KV, Taurog JD, Hünig T, Herrmann T, Reichardt HM, Weishaupt A, Kerkau T (2013)
CD8? T cell help is required for efficient induction of EAE in Lewis rats. 
J Neuroimmunol 260(1-2):17-27.

Dams J, Siebert U, Bornschein B, Volkmann J, Deuschl G, Oertel WH, Dodel R, Reese JP (2013)
Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.
Mov Disord 28(6):763-71.

Deiß A, Brecht I, Haarmann A, Buttmann M (2013)
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Expert Rev Neurother 13(3):313-35.

Doppler K, Knop S, Einsele H, Sommer C, Wessig C (2013)
Sporadic late onset nemaline myopathy and immunoglobulin deposition disease.
Muscle Nerve 48(6):983-8.

Doppler K, Sommer C (2013)
Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment.
Nervenarzt 84(12):1428-35.

Doppler K, Werner C, Sommer C (2013)
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies. J Peripher Nerv Syst 18(2):168-76.

Elias J, Heuschmann PU, Schmitt C, Eckhardt F, Boehm H, Maier S, Kolb-Mäurer A, Riedmiller H, Müllges W, Weisser C, Wunder C, Frosch M, Vogel U (2013)
Prevalence dependent calibration of a predictive model for nasal carriage of methicillin-resistant Staphylococcus aureus.
BMC Infect Dis 13:111.

Göbel K, Wedell JH, Herrmann AM, Wachsmuth L, Pankratz S, Bittner S, Budde T, Kleinschnitz C, Faber C, Wiendl H, Meuth SG (2013)
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Exp Neurol 248:62-71.

Groh J, Kühl TG, Ip CW, Nelvagal HR, Sri S, Duckett S, Mirza M, Langmann T, Cooper JD, Martini R (2013) 
Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis. 
Brain 136(Pt 4):1083-101.

Hansen N, Grünewald B, Weishaupt A, Colaço MN, Toyka KV, Sommer C, Geis C (2013)
Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.
Exp Neurol 239:202-9.

Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, Kleinschnitz C, Rauer S, Kuhle J, Stangel M, Weber F, Uhr M, Linnebank M, Wildemann B, Jarius S, Guger M, Ayzenberg I, Chan A, Zettl U, Wiendl H, Pilz G, Hitzl W, Weber JR, Kraus J (2013)
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Mult Scler 19(9):1209-12.

Häuser W, Urrútia G, Tort S, Uçeyler N, Walitt B. (2013) Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 1:CD010292.

International Multiple Sclerosis Genetics Consortium , Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA, Pérez J, Damotte V, Booth D, Lopez de Lapuente A, Broer L, Schilling M, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Blaschke P, Buttmann M, Chan A, Compston A, Cournu-Rebeix I, Dörner T, Epplen JT, Fernández Ó, Gerdes LA, Guillot-Noël L, Hartung HP, Hoffjan S, Izquierdo G, Kemppinen A, Kroner A, Kubisch C, Kümpfel T, Li SC, Lindenberger U, Lohse P, Lubetzki C, Luessi F, Malhotra S, Mescheriakova J, Montalban X, Papeix C, Paredes LF, Rieckmann P, Steinhagen-Thiessen E, Winkelmann A, Zettl UK, Hintzen R, Vandenbroeck K, Stewart G, Fontaine B, Comabella M, Urcelay E, Matesanz F, Sawcer S, Bertram L, Zipp F (2013)
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Brain 136(Pt 6):1778-82.

Johannsen S, Berberich C, Metterlein T, Roth C, Reiners K, Roewer N, Schuster F (2013)
Screening test for malignant hyperthermia in patients with persistent hyperCKemia: a pilot study.
Muscle Nerve 47(5):677-81.

Karle KN, Schüle R, Klebe S, Otto S, Frischholz C, Liepelt-Scarfone I, Schöls L (2013)
Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP).
Orphanet J Rare Dis 8:158.

Kaufmann T, Schulz SM, Köblitz A, Renner G, Wessig C, Kübler A (2013)
Face stimuli effectively prevent brain-computer interface inefficiency in patients with neurodegenerative disease.
Clin Neurophysiol 124(5):893-900.

Klebe S, Golmard JL, Nalls MA, Saad M, Singleton AB, Bras JM, Hardy J, Simon-Sanchez J, Heutink P, Kuhlenbäumer G, Charfi R, Klein C, Hagenah J, Gasser T, Wurster I, Lesage S, Lorenz D, Deuschl G, Durif F, Pollak P, Damier P, Tison F, Durr A, Amouyel P, Lambert JC, Tzourio C, Maubaret C, Charbonnier-Beaupel F, Tahiri K, Vidailhet M, Martinez M, Brice A, Corvol JC, French Parkinson's Disease Genetics Study Group , International Parkinson's Disease Genomics Consortium (IPDGC) , Agid Y, Anheim M, Bonnet AM, Borg M, Brice A, Broussolle E, Corvol JC, Damier P, Destée A, Durr A, Durif F, Klebe S, Lohmann E, Martinez M, Penet C, Pollak P, Krack P, Rascol O, Tison F, Tranchant C, Vérin M, Viallet F, Plagnol V, Bras JM, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simón-Sánchez J, Schulte C, Lesage S, Sveinbjörnsdóttir S, Amouyel P, Arepalli S, Band G, Barker RA, Bellinguez C, Ben-Shlomo Y, Berendse HW, Berg D, Bhatia K, de Bie RM, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Brockmann K, Brooks J, Burn DJ, Charlesworth G, Chen H, Chinnery PF, Chong S, Clarke CE, Cookson MR, Cooper JM, Corvol JC, Counsell C, Damier P, Dartigues JF, Deloukas P, Dexter DT, van Dijk KD, Dillman A, Durif F, Edkins S, Evans JR, Foltynie T, Freeman C, Gao J, Gardner M, Gibbs R, Goate A, Gray E, Guerreiro R, Gústafsson O, Harris C, Hellenthal G, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang X, Huber H, Hudson G, Hunt SE, Huttenlocher J, Illig T, Jónsson PV, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, McNeill A, Moorby C, Morris H, Morrison KE, Mudanohwo E, O'Sullivan SS, Pearson J, Pearson R, Perlmutter JS, Pétursson H, Pirinen M, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Sidransky E, de Silva R, Smith C, Spencer CC, Stefánsson H, Steinberg S, Stockton JD, Strange A, Su Z, Talbot K, Tanner CM, Tashakkori-Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden G, Vandrovcova J, Velseboer D, Vidailhet M, Vukcevic D, Walker R, van de Warrenburg B, Weale ME, Wickremaratchi M, Williams N, Williams-Gray CH, Winder-Rhodes S, Martinez M, Donnelly P, Hardy J, Heutink P, Brice A, Gasser T, Wood NW, Singleton AB (2013)
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
J Neurol Neurosurg Psychiatry 84(6):666-73.

Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Göbel K, Schuhmann MK, Langhauser F, Helluy X, Schwarz T, Bittner S, Mayer CT, Brede M, Varallyay C, Pham M, Bendszus M, Jakob P, Magnus T, Meuth SG, Iwakura Y, Zernecke A, Sparwasser T, Nieswandt B, Stoll G, Wiendl H (2013)
Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. 
Blood 121(4):679-91.

Kosacka J, Nowicki M, Blüher M, Baum P, Stockinger M, Toyka KV, Klöting I, Stumvoll M, Serke H, Bechmann I, Klöting N (2013)
Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy.
Exp Neurol 250:125-35.

Kraft P, Göb E, Schuhmann MK, Göbel K, Deppermann C, Thielmann I, Herrmann AM, Lorenz K, Brede M, Stoll G, Meuth SG, Nieswandt B, Pfeilschifter W, Kleinschnitz C (2013)
FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
Stroke 44(11):3202-10. 

Kraft P, Schwarz T, Göb E, Heydenreich N, Brede M, Meuth SG, Kleinschnitz C (2013)
The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis.
Exp Neurol 247:80-90.

Léger JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Shebl A, Bauhofer A, Zenker O, Merkies IS, PRIMA study investigators , De Bleecker J, Robberecht W, Saarela M, Franques J, Léger J-, Morales R, Sommer C, Nguento A, Schmidt J, Schrey Ch, Kamienowski J, Stelmasiak Z, Zwoli?ska G (2013)
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
J Peripher Nerv Syst 18(2):130-40.

Leinders M, Knaepen L, De Kock M, Sommer C, Hermans E, Deumens R (2013)
Up-regulation of spinal microglial Iba-1 expression persists after resolution of neuropathic pain hypersensitivity.
Neurosci Lett 554:146-50.

Lenz M, Uçeyler N, Frettlöh J, Höffken O, Krumova EK, Lissek S, Reinersmann A, Sommer C, Stude P, Waaga-Gasser AM, Tegenthoff M, Maier C (2013)
Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months.
Pain 154(10):2142-9.

Lesage S, Le Ber I, Condroyer C, Broussolle E, Gabelle A, Thobois S, Pasquier F, Mondon K, Dion PA, Rochefort D, Rouleau GA, Dürr A, Brice A, French Parkinson's Disease Genetics Study Group (2013)
C9orf72 repeat expansions are a rare genetic cause of parkinsonism.
Brain 136(Pt 2):385-91.

Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA, Blaschke P, Gerdes LA, Kroner A, Luessi F, Cournu-Rebeix I, Hoffjan S, Winkelmann A, Touze E, Pico F, Corcia P, Otaegui D, Antigüedad A, Alcina A, Comabella M, Montalban X, Olascoaga J, Matesanz F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Rieckmann P, Hartung HP, Aktas O, Lohse P, Buttmann M, Kümpfel T, Kubisch C, Zettl UK, Epplen JT, Fontaine B, Zipp F, Vandenbroeck K, Bertram L (2013)
Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.
J Med Genet 50(3):140-3.

Martini R, Klein D, Groh J (2013)
Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditions.
Am J Pathol 183(3):655-60.

Morowski M, Vögtle T, Kraft P, Kleinschnitz C, Stoll G, Nieswandt B (2013)
Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice.
Blood 121(24):4938-47.

Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD (2013)
Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.
J Physiol 591(Pt 10):2747-62.

Müllges W (2013)
Weaning--definition and clinical context from the neurologist's view. 
Anasthesiol Intensivmed Notfallmed Schmerzther 48(10):616-21.

Offen N, Flemming J, Kamawal H, Ahmad R, Wolber W, Geis C, Zaehres H, Schöler HR, Ehrenreich H, Müller AM, Sirén AL (2013)
Effects of erythropoietin in murine-induced pluripotent cell-derived panneural progenitor cells.
Mol Med 19:399-408.

Polak T, Zeller D, Fallgatter AJ, Metzger FG (2013)
Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.
Neuroreport 24(5):251-3.

Pötter-Nerger M, Habben A, Herzog J, Falk D, Mehdorn MH, Deuschl G, Volkmann J (2013)
Kinematic effects of subthalamic stimulation on reach-to-grasp movements in Parkinson's disease.
Parkinsonism Relat Disord 19(1):32-6.

Pötter-Nerger M, Volkmann J (2013)
Deep brain stimulation for gait and postural symptoms in Parkinson's disease.
Mov Disord 28(11):1609-15.

Radermacher KA, Wingler K, Langhauser F, Altenhöfer S, Kleikers P, Hermans JJ, Hrab? de Angelis M, Kleinschnitz C, Schmidt HH (2013)
Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.
Antioxid Redox Signal 18(12):1418-27.

Rak K, Frenz S, Radeloff A, Groh J, Jablonka S, Martini R, Hagen R, Mlynski R (2013)
Mutation of the TBCE gene causes disturbance of microtubules in the auditory nerve and cochlear outer hair cell degeneration accompanied by progressive hearing loss in the pmn/pmn mouse.
Exp Neurol 250:333-40.

Reich MM, Kühn AA, Volkmann J (2013)
Deep brain stimulation. New target areas and new indications.
Nervenarzt 84(8):927-36.

Schmidt A, Minnerup J, Kleinschnitz C (2013)
Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
Expert Opin Emerg Drugs 18(2):109-20.

Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H (2013)
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Neurology 81(10):865-71.

Sommer C (2013)
Neuropathic pain: pathophysiology, assessment, and therapy.
Schmerz 27(6):619-32; quiz 633-4.

Stegner D, Thielmann I, Kraft P, Frohman MA, Stoll G, Nieswandt B (2013)
Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report. 
Arterioscler Thromb Vasc Biol 33(9):2212-7.

Treede RD, Wagner T, Kern KU, Husstedt IW, Arendt G, Birklein F, Cegla T, Freynhagen R, Gockel HH, Heskamp ML, Jager H, Joppich R, Maier C, Leffler A, Nagelein HH, Rolke R, Seddigh S, Sommer C, Stander S, Wasner G, Baron R (2013)
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
Curr Med Res Opin 29(5):527-38.

Üçeyler N, Kahn AK, Kramer D, Zeller D, Casanova-Molla J, Wanner C, Weidemann F, Katsarava Z, Sommer C (2013)
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study.
BMC Neurol 13:47.

Üçeyler N, Sommer C, Walitt B, Häuser W (2013)
Anticonvulsants for fibromyalgia.
Cochrane Database Syst Rev 10:CD010782.

Üçeyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, Casanova-Molla J, Reiners K, Sommer C (2013)
Small fibre pathology in patients with fibromyalgia syndrome.
Brain 136(Pt 6) 1857-67.

Volkmann J, Albanese A, Antonini A, Chaudhuri KR, Clarke CE, de Bie RM, Deuschl G, Eggert K, Houeto JL, Kulisevsky J, Nyholm D, Odin P, Østergaard K, Poewe W, Pollak P, Rabey JM, Rascol O, Ruzicka E, Samuel M, Speelman H, Sydow O, Valldeoriola F, van der Linden C, Oertel W (2013)
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.
J Neurol 260(11):2701-14.

Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, Müller-Reible C, Vorgerd M, Urban P, Schrank B, Deschauer M, Schlotter-Weigel B, Kohnen R, Lochmüller H (2013)
Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.
Orphanet J Rare Dis 8:26.

Weidemann F, Niemann M, Störk S, Breunig F, Beer M, Sommer C, Herrmann S, Ertl G, Wanner C (2013)
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications.
J Intern Med 274(4):331-41.

Weise D, Mann J, Ridding M, Eskandar K, Huss M, Rumpf JJ, Di Lazzaro V, Mazzone P, Ranieri F, Classen J (2013)
Microcircuit mechanisms involved in paired associative stimulation-induced depression of corticospinal excitability.
J Physiol 591(Pt 19):4903-20.

Witt K, Granert O, Daniels C, Volkmann J, Falk D, van Eimeren T, Deuschl G (2013)
Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
Brain 136(Pt 7):2109-19.

Zeller D, Markulin F, Monoranu CM, Solymosi L, Stoll G (2013)
Spreading along white matter tracts?--A case of progressive multifocal leukoencephalopathy with unusual MRI presentation.
Clin Neurol Neurosurg 115(5):638-40.

Zeuner KE, Knutzen A, Pedack L, Hallett M, Deuschl G, Volkmann J (2013)
Botulinum neurotoxin treatment improves force regulation in writer's cramp.
Parkinsonism Relat Disord 19(6):611-6.

Albert-Weissenberger C, Stetter C, Meuth SG, Göbel K, Bader M, Sirén AL, Kleinschnitz C (2012)
Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.
J Cereb Blood Flow Metab 32(9):1747-56.

Andreatta M, Puschmann AK, Sommer C, Weyers P, Pauli P, Mühlberger A (2012)
Altered processing of emotional stimuli in migraine: an event-related potential study.
Cephalalgia 32(15):1101-8.

Basse-Lüsebrink TC, Kampf T, Fischer A, Sturm VJ, Neumann D, Köstler H, Hahn D, Stoll G, Jakob PM (2012)
SAR-reduced spin-echo-based Bloch-Siegert B(1)(+) mapping: BS-SE-BURST.
Magn Reson Med 68(2):529-36.

Basse-Lüsebrink TC, Sturm VJ, Kampf T, Stoll G, Jakob PM (2012)
Fast CPMG-based Bloch-Siegert B(1)+ mapping.
Magn Reson Med 67(2):405-18.

Benkert TF, Dietz L, Hartmann EM, Leich E, Rosenwald A, Serfling E, Buttmann M, Berberich-Siebelt F (2012)
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
PLoS ONE 7(12):e52208.

Brecht I, Weissbrich B, Braun J, Toyka KV, Weishaupt A, Buttmann M (2012)
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
PLoS ONE 7(7):e40431.

De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C (2012)
von Willebrand factor: an emerging target in stroke therapy.
Stroke 43(2):599-606.

Doppler K, Lindner A, Schütz W, Schütz M, Bornemann A (2012)
Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study. 
Brain Pathol 22(1):32-40.

Doppler K, Werner C, Henneges C, Sommer C (2012)
Analysis of myelinated fibers in human skin biopsies of patients with neuropathies.
J Neurol 259(9):1879-87.

Dufke C, Schlipf N, Schüle R, Bonin M, Auer-Grumbach M, Stevanin G, Depienne C, Kassubek J, Klebe S, Klimpe S, Klopstock T, Otto S, Poths S, Seibel A, Stolze H, Gal A, Schöls L, Bauer P (2012)
A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes.
Neurogenetics 13 (3):215-27.

Dupuis L, Dengler R, Heneka MT, Meyer T, Zierz S, Kassubek J, Fischer W, Steiner F, Lindauer E, Otto M, Dreyhaupt J, Grehl T, Hermann A, Winkler AS, Bogdahn U, Benecke R, Schrank B, Wessig C, Grosskreutz J, Ludolph AC, GERP ALS Study Group , Borisow N, Holm T, Maier A, Meyer T, Budde P, Grehl T, Guettsches AK, Bewersdorff M, Heneka M, Hermann A, Storch A, Frank T, Göricke B, Weishaupt J, Eger K, Hanisch F, Zierz S, Cordes AL, Dengler R, Koerner S, Kollewe K, Petri S, Grosskreutz J, Kunze A, Prell T, Ringer T, Zinke J, Anneser J, Borasio GD, Chahli C, Winkler AS, Boentert M, Stubbe-Draeger B, Young P, Bogdahn U, Franz S, Haringer V, Weidner N, Benecke R, Meister S, Prudlo J, Wittstock M, Dorst J, Hendrich C, Ludolph AC, Sperfeld AD, Weiland U, Neidhardt S, Schrank B, Beck M, Kraft P, Toyka K, Ulzheimer J, Wessig C (2012)
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis.
PLoS ONE 7(6):e37885.

Eich W, Häuser W, Arnold B, Jäckel W, Offenbächer M, Petzke F, Schiltenwolf M, Settan M, Sommer C, Tölle T, Uçeyler N, Henningsen P, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2012)
Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis.
Schmerz 26(3):247-58.

Fasano A, Herzog J, Raethjen J, Rose FE, Volkmann J, Falk D, Deuschl G (2012)
Lower limb joints kinematics in essential tremor and the effect of thalamic stimulation.
Gait Posture 36(2):187-93.

Gajdos P, Chevret S, Toyka KV (2012)
Intravenous immunoglobulin for myasthenia gravis.
Cochrane Database Syst Rev 12:CD002277.

Geis C, Grünewald B, Weishaupt A, Wultsch T, Toyka KV, Reif A, Sommer C (2012) Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. 
J Neural Transm 119(8):981-5.

Groh J, Weis J, Zieger H, Stanley ER, Heuer H, Martini R (2012)
Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X.
Brain 135(Pt 1):88-104.

Hackel D, Krug SM, Sauer RS, Mousa SA, Böcker A, Pflücke D, Wrede EJ, Kistner K, Hoffmann T, Niedermirtl B, Sommer C, Bloch L, Huber O, Blasig IE, Amasheh S, Reeh PW, Fromm M, Brack A, Rittner HL (2012)
Transient opening of the perineurial barrier for analgesic drug delivery.
Proc Natl Acad Sci U S A 109(29):E2018-27.

Hansen N, Obermann M, Uçeyler N, Zeller D, Mueller D, Yoon MS, Reiners K, Sommer C, Katsarava Z (2012)
Clinical application of pain-related evoked potentials.
Schmerz 26(1):8-15.

Häuser W, Wolfe F, Tölle T, Uçeyler N, Sommer C (2012)
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.
CNS Drugs 26(4):297-307.

Heydenreich N, Nolte MW, Göb E, Langhauser F, Hofmeister M, Kraft P, Albert-Weissenberger C, Brede M, Varallyay C, Göbel K, Meuth SG, Nieswandt B, Dickneite G, Stoll G, Kleinschnitz C (2012)
C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms.
Stroke 43(9):2457-67.

Holzapfel BM, Heinen F, Holzapfel DE, Reiners K, Nöth U, Rudert M (2012)
Nerve lesions after minimally invasive total hip arthroplasty.
Orthopade 41(5):354-64.

Horn M, Baumann R, Pereira JA, Sidiropoulos PN, Somandin C, Welzl H, Stendel C, Lühmann T, Wessig C, Toyka KV, Relvas JB, Senderek J, Suter U (2012)
Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
Brain 135(Pt 12):3567-83.

Ingram CJ, Weale ME, Plaster CA, Morrison KE, Goodall EF, Pall HS, Beck M, Jablonka S, Sendtner M, Fisher EM, Bradman N, Kasperavi?i?t? D (2012)
Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosis.
Amyotroph Lateral Scler 13(4):341-6.

Ip CW, Kroner A, Groh J, Huber M, Klein D, Spahn I, Diem R, Williams SK, Nave KA, Edgar JM, Martini R (2012)
Neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse.
PLoS ONE 7(8):e42554.

Isaias IU, Volkmann J, Marzegan A, Marotta G, Cavallari P, Pezzoli G (2012)
The influence of dopaminergic striatal innervation on upper limb locomotor synergies.
PLoS ONE 7(12):e51464.

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. 
J Neuroinflammation 9:14.

Kleinschnitz C, Plesnila N (2012)
Experimental therapy approaches for ischemic stroke.
Nervenarzt 83(10):1275-81.

Kraft P, De Meyer SF, Kleinschnitz C (2012)
Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'.
J Cereb Blood Flow Metab 32(10):1831-40.

Kraft P, Nieswandt B, Stoll G, Kleinschnitz C (2012)
Acute ischemic stroke. New approaches to antithrombotic treatment.
Nervenarzt 83(4):435-49.

Krannich JH, Tobias T, Broscheit J, Leyh R, Müllges W (2012)
Diabetes severely affects attentional performance after coronary artery bypass grafting.
J Cardiothorac Surg 7:115.

Küster O, Schittenhelm J, Schwartz O, Meyermann R, Schuhmann MU (2012)
Paediatric clear cell meningioma with multiple distant recurrences after presumed intra-operative cell spread.
Childs Nerv Syst 28(6):925-31.

Langhauser F, Göb E, Kraft P, Geis C, Schmitt J, Brede M, Göbel K, Helluy X, Pham M, Bendszus M, Jakob P, Stoll G, Meuth SG, Nieswandt B, McCrae KR, Kleinschnitz C (2012)
Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.
Blood 120(19):4082-92.

Lee NY, Rieckmann P, Kang YS (2012)
The Changes of P-glycoprotein Activity by Interferon-? and Tumor Necrosis Factor-? in Primary and Immortalized Human Brain Microvascular Endothelial Cells.
Biomol Ther (Seoul) 20(3):293-8.

Lesage S, Condroyer C, Klebe S, Lohmann E, Durif F, Damier P, Tison F, Anheim M, Honoré A, Viallet F, Bonnet AM, Ouvrard-Hernandez AM, Vidailhet M, Durr A, Brice A, French Parkinson's Disease Genetics Study Group , Agid Y, Anheim M, Bonnet A-, Borg M, Brice A, Broussolle E, Corvol J-, Damier P, Destée A, Dürr A, Durif F, Klebe S, Krack P, Lesage S, Lohmann E, Martinez M, Pollak P, Rascol O, Tison F, Tranchant C, Vérin M, Viallet F, Vidailhet M (2012)
EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?
Neurobiol Aging 33(9):2233.e1-2233.e5.

Magnus T, Wiendl H, Kleinschnitz C (2012)
Immune mechanisms of stroke.
Curr Opin Neurol 25(3):334-40.

Matthes F, Stroobants S, Gerlach D, Wohlenberg C, Wessig C, Fogh J, Gieselmann V, Eckhardt M, D'Hooge R, Matzner U (2012)
Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Hum Mol Genet 21(11):2599-609.

Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C (2012)
Neuroprotection for stroke: current status and future perspectives.
Int J Mol Sci 13(9):11753-72.

Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD (2012)
Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
Exp Neurol 237(2):286-95.

Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Prüss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies. 
Neurology 79(23):2241-8.

Onal-Hartmann C, Fiorio M, Gentner R, Zeller D, Pauli P, Classen J (2012)
After-training emotional interference may modulate sequence awareness in a serial reaction time task.
Exp Brain Res 219(1):75-84.

Pan B, Grünewald B, Nguyen T, Farah M, Polydefkis M, McDonald J, Schramm LP, Toyka KV, Höke A, Griffin JW (2012)
The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies.
Exp Neurol 236(1):6-18.

Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP (2012)
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. 
Mult Scler 18(12):1721-36.

Pham M, Stoll G, Nieswandt B, Bendszus M, Kleinschnitz C (2012)
Blood coagulation factor XII--a neglected player in stroke pathophysiology.
J Mol Med 90(2):119-26.

Pleines I, Hagedorn I, Gupta S, May F, Chakarova L, van Hengel J, Offermanns S, Krohne G, Kleinschnitz C, Brakebusch C, Nieswandt B (2012)
Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis.
Blood 119(4):1054-63.

Pötter-Nerger M, Reich MM, Colebatch JG, Deuschl G, Volkmann J (2012)
Differential effect of dopa and subthalamic stimulation on vestibular activity in Parkinson's disease.
Mov Disord 27(10):1268-75.

Reese R, Pinsker MO, Herzog J, Wodarg F, Steigerwald F, Pötter-Nerger M, Falk D, Deuschl G, Mehdorn HM, Volkmann J (2012)
The atypical subthalamic nucleus--an anatomical variant relevant for stereotactic targeting.
Mov Disord 27(4):544-8.

Schneider-Hohendorf T, Schwab N, Uçeyler N, Göbel K, Sommer C, Wiendl H (2012)
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy.
Neurology 78(6):402-8.

Schwab N, Höhn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Brück W, Wiendl H (2012)
Immunological and clinical consequences of treating a patient with natalizumab.
Mult Scler 18(3):335-44.

Schwab N, Ulzheimer JC, Fox RJ, Schneider-Hohendorf T, Kieseier BC, Monoranu CM, Staugaitis SM, Welch W, Jilek S, Du Pasquier RA, Brück W, Toyka KV, Ransohoff RM, Wiendl H (2012)
Fatal PML associated with efalizumab therapy: insights into integrin ?L?2 in JC virus control.
Neurology 78(7):458-67; discussion 465.

Shields SD, Cheng X, Uçeyler N, Sommer C, Dib-Hajj SD, Waxman SG (2012)
Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury.
J Neurosci 32(32):10819-32.

Skogseid IM, Ramm-Pettersen J, Volkmann J, Kerty E, Dietrichs E, Røste GK (2012)
Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study.
Eur J Neurol 19(4):610-5.

Sommer C, Häuser W, Alten R, Petzke F, Späth M, Tölle T, Uçeyler N, Winkelmann A, Winter E, Bär KJ, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2012)
Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline.
Schmerz 26(3):297-310.

Sommer C, Häuser W, Burgmer M, Engelhardt R, Gerhold K, Petzke F, Schmidt-Wilcke T, Späth M, Tölle T, Uçeyler N, Wang H, Winkelmann A, Thieme K, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2012)
Etiology and pathophysiology of fibromyalgia syndrome.
Schmerz 26(3):259-67.

Steigerwald F, Volkmann J (2012)
Deep brain stimulation for movement disorders.
Nervenarzt 83(8):988-93.

Stoll G, Basse-Lüsebrink T, Weise G, Jakob P (2012)
Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons. 
Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(4):438-47.

Sturm VJ, Basse-Lüsebrink TC, Kampf T, Stoll G, Jakob PM (2012)
Improved encoding strategy for CPMG-based Bloch-Siegert B(1)(+) mapping.
Magn Reson Med 68(2):507-15.

Südmeyer M, Volkmann J, Wojtecki L, Deuschl G, Schnitzler A, Möller B (2012)
Deep brain stimulation - expectations and doubts. A nationwide questionnaire study of patients with Parkinson's disease and their family members.
Nervenarzt 83(4):481-6.

Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C (2012)
Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
Int J Stroke 7(5):407-18.

Thielmann I, Stegner D, Kraft P, Hagedorn I, Krohne G, Kleinschnitz C, Stoll G, Nieswandt B (2012)
Redundant functions of phospholipases D1 and D2 in platelet ?-granule release.
J Thromb Haemost 10(11):2361-72.

Thier S, Lorenz D, Nothnagel M, Poremba C, Papengut F, Appenzeller S, Paschen S, Hofschulte F, Hussl AC, Hering S, Poewe W, Asmus F, Gasser T, Schöls L, Christensen K, Nebel A, Schreiber S, Klebe S, Deuschl G, Kuhlenbäumer G (2012)
Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor.
Neurology 79(3):243-8.

Üçeyler N, He L, Kahn AK, Breunig F, Müllges W, Sommer C (2012)
Cerebral blood flow in patients with Fabry disease as measured by Doppler sonography is not different from that in healthy individuals and is unaffected by treatment.
J Ultrasound Med 31(3):463-8.

Üçeyler N, Sommer C (2012)
Fabry disease: diagnosis and treatment.
Schmerz 26(5):609-19.

van Kruchten R, Braun A, Feijge MA, Kuijpers MJ, Rivera-Galdos R, Kraft P, Stoll G, Kleinschnitz C, Bevers EM, Nieswandt B, Heemskerk JW (2012)
Antithrombotic potential of blockers of store-operated calcium channels in platelets.
Arterioscler Thromb Vasc Biol 32(7):1717-23.

Volkmann J, Wolters A, Kupsch A, Müller J, Kühn AA, Schneider GH, Poewe W, Hering S, Eisner W, Müller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Classen J, Naumann M, Benecke R, DBS study group for dystonia , Benecke R, Volkmann J, Gierl L, Gierl L, Benecke R, Deuschl G, Müller J, Pinsker MO, Poewe W, Volkmann J, Wolters A, Mehdorn MH, Gruber D, Kivi A, Kühn AA, Kupsch A, Müller B, Schneider GH, Trottenberg T, Schnitzler A, Sturm V, Timmermann L, Voges J, Wojtecki L, Nikkah G, Pinsker M, Prokop T, Vesper J, Kloss M, Krause M, Eisner W, Fiegele T, Müller J, Hering S, Poewe W, Deuschl G, Herzog J, Mehdorn MM, Pinsker MO, Pötter M, Steigerwald F, Volkmann J, Boothe HW, Brentrup A, Vollmer-Haase J, Roeste GK, Skogseid IM, Benecke R, Müller JU, Wittstock M, Wolters A, Classen J, Naumann M, Schramm A (2012)
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.
Lancet Neurol 11(12):1029-38.

Weidemann F, Niemann M, Sommer C, Beer M, Breunig F, Wanner C (2012)
Interdisciplinary approach towards female patients with Fabry disease.
Eur J Clin Invest 42(4):455-62.

Weis J, Brandner S, Lammens M, Sommer C, Vallat JM (2012)
Processing of nerve biopsies: a practical guide for neuropathologists.
Clin Neuropathol 31(1):7-23.

Weise D, Gentner R, Zeller D, Nagel A, Reinsberger C, Rumpf JJ, Classen J (2012)
Focal hand dystonia: lack of evidence for abnormality of motor representation at rest.
Neurology 78(2):122-8.

Weise G, Hupp M, Kerstan A, Buttmann M (2012)
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.
J Clin Neurosci 19(9):1312-3.

Wessig C, Bendszus M, Reiners K, Pham M (2012)
Lesions of the peripheral nerves: MR neurography as an innovative supplement to electrodiagnostics.
Handchir Mikrochir Plast Chir 44(3):155-62.

Wieser MJ, Klupp E, Weyers P, Pauli P, Weise D, Zeller D, Classen J, Mühlberger A (2012)
Reduced early visual emotion discrimination as an index of diminished emotion processing in Parkinson's disease? - Evidence from event-related brain potentials.
Cortex 48(9):1207-17.

Wodarg F, Herzog J, Reese R, Falk D, Pinsker MO, Steigerwald F, Jansen O, Deuschl G, Mehdorn HM, Volkmann J (2012)
Stimulation site within the MRI-defined STN predicts postoperative motor outcome. 
Mov Disord 27(7):874-9.

Zeller D, Dang SY, Weise D, Rieckmann P, Toyka KV, Classen J (2012)
Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.
BMC Neurol 12:92.